PER3 and prostate carcinoma: Additionally, Cai et al. (Cai et al., 2018) noted a downregulation of PER3 gene in prostate cancer patients with paclitaxel-resistant, while the paclitaxel sensitivity of cancer cells could be rescued by overexpressing the PER3 gene.